Meng Y X, Virutamasen P
Family Planning Research Institute, Zhejiang Academy of Medical Sciences, Hangzhou, People's Republic of China.
Contraception. 1991 Jul;44(1):73-82. doi: 10.1016/0010-7824(91)90107-q.
Endometrial bleeding and alteration in blood coagulation, fibrinolysis, ovarian function and endometrial morphology were studied in twelve normally menstruating women who received the injectable contraceptive norethisterone enanthate (NET-EN) 200mg at 60-day intervals. Levels of clotting factor VII declined significantly during episodes of irregular bleeding compared to those during both normal pretreatment menstruation and the bleeding-free period during treatment. Antithrombin III and fibrinolytic activity, expressed by euglobulin lysis time, showed no marked change. The average level of progesterone during the bleeding-free period was slightly but significantly lower than that during the bleeding period. There were no significant alterations in the mean levels of estradiol and the ratio of estradiol to progesterone. The endometrial biopsies showed considerable individual variation and seem to be independent of the effects of NET-EN on ovarian function.
对12名正常月经周期的女性进行了研究,她们每隔60天注射200mg庚酸炔诺酮(NET-EN)这种注射用避孕药。研究了子宫内膜出血以及凝血、纤维蛋白溶解、卵巢功能和子宫内膜形态的变化。与治疗前正常月经期间和治疗期间无出血期相比,不规则出血期间凝血因子VII水平显著下降。抗凝血酶III和以优球蛋白溶解时间表示的纤维蛋白溶解活性无明显变化。无出血期的孕酮平均水平略低于出血期,但差异有统计学意义。雌二醇平均水平以及雌二醇与孕酮的比值无显著变化。子宫内膜活检显示个体差异较大,似乎与NET-EN对卵巢功能的影响无关。